Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 9 | 2021 | 99 | 2.740 |
Why?
|
| Patellofemoral Joint | 5 | 2022 | 7 | 2.140 |
Why?
|
| Joint Instability | 5 | 2022 | 46 | 1.820 |
Why?
|
| Knee Joint | 8 | 2022 | 118 | 1.310 |
Why?
|
| Bone Transplantation | 5 | 2021 | 28 | 1.100 |
Why?
|
| Shoulder Joint | 5 | 2022 | 83 | 1.020 |
Why?
|
| Patella | 4 | 2022 | 9 | 0.980 |
Why?
|
| Rotator Cuff Injuries | 4 | 2021 | 58 | 0.960 |
Why?
|
| Cartilage Diseases | 5 | 2018 | 11 | 0.950 |
Why?
|
| Humans | 31 | 2022 | 5837 | 0.930 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 5 | 2022 | 24 | 0.910 |
Why?
|
| Patellar Dislocation | 2 | 2022 | 5 | 0.880 |
Why?
|
| Tendon Injuries | 3 | 2021 | 23 | 0.860 |
Why?
|
| Shoulder Dislocation | 2 | 2022 | 31 | 0.830 |
Why?
|
| Allografts | 5 | 2021 | 18 | 0.820 |
Why?
|
| Bankart Lesions | 1 | 2021 | 6 | 0.700 |
Why?
|
| Knee Injuries | 3 | 2020 | 25 | 0.660 |
Why?
|
| Ligaments, Articular | 4 | 2022 | 8 | 0.600 |
Why?
|
| Femur | 5 | 2022 | 134 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 150 | 0.570 |
Why?
|
| Anterior Cruciate Ligament | 3 | 2022 | 37 | 0.560 |
Why?
|
| Stifle | 1 | 2018 | 5 | 0.540 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 65 | 0.530 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2014 | 13 | 0.430 |
Why?
|
| Menisci, Tibial | 4 | 2022 | 21 | 0.410 |
Why?
|
| Transplantation, Homologous | 6 | 2021 | 38 | 0.410 |
Why?
|
| Tibia | 4 | 2022 | 60 | 0.390 |
Why?
|
| Biomechanical Phenomena | 5 | 2022 | 156 | 0.380 |
Why?
|
| Shoulder | 3 | 2022 | 40 | 0.370 |
Why?
|
| Cadaver | 3 | 2022 | 79 | 0.330 |
Why?
|
| Orthopedic Procedures | 3 | 2018 | 38 | 0.310 |
Why?
|
| Retrospective Studies | 6 | 2022 | 584 | 0.310 |
Why?
|
| Animals | 5 | 2022 | 1349 | 0.310 |
Why?
|
| Arthroscopy | 3 | 2021 | 123 | 0.310 |
Why?
|
| Anterior Cruciate Ligament Injuries | 2 | 2022 | 25 | 0.310 |
Why?
|
| Adult | 12 | 2022 | 1670 | 0.270 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 333 | 0.270 |
Why?
|
| Rotator Cuff | 2 | 2021 | 47 | 0.250 |
Why?
|
| Osteotomy | 3 | 2022 | 26 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 45 | 0.240 |
Why?
|
| Osteoarthritis, Knee | 2 | 2022 | 88 | 0.230 |
Why?
|
| Femoracetabular Impingement | 2 | 2020 | 46 | 0.230 |
Why?
|
| Young Adult | 7 | 2021 | 421 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 207 | 0.210 |
Why?
|
| Middle Aged | 9 | 2022 | 1775 | 0.200 |
Why?
|
| Male | 11 | 2022 | 3399 | 0.200 |
Why?
|
| Treatment Outcome | 7 | 2022 | 601 | 0.200 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 60 | 0.190 |
Why?
|
| Female | 10 | 2022 | 3346 | 0.190 |
Why?
|
| Sports Medicine | 1 | 2022 | 6 | 0.180 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 15 | 0.180 |
Why?
|
| Risk Factors | 2 | 2021 | 499 | 0.180 |
Why?
|
| Glenoid Cavity | 1 | 2022 | 6 | 0.180 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2022 | 2 | 0.180 |
Why?
|
| Electrosurgery | 1 | 2021 | 2 | 0.180 |
Why?
|
| Sheep | 1 | 2021 | 7 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2021 | 8 | 0.180 |
Why?
|
| Recurrence | 1 | 2021 | 52 | 0.170 |
Why?
|
| Humeral Head | 2 | 2022 | 8 | 0.170 |
Why?
|
| Tendons | 2 | 2019 | 25 | 0.170 |
Why?
|
| Computers | 1 | 2021 | 6 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2021 | 54 | 0.170 |
Why?
|
| Return to Work | 1 | 2020 | 8 | 0.160 |
Why?
|
| Adolescent | 5 | 2021 | 488 | 0.160 |
Why?
|
| Fractures, Stress | 1 | 2020 | 6 | 0.160 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2020 | 10 | 0.160 |
Why?
|
| Psychometrics | 1 | 2020 | 52 | 0.150 |
Why?
|
| Cartilage | 1 | 2018 | 23 | 0.140 |
Why?
|
| Anesthetics, Local | 2 | 2009 | 34 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2018 | 34 | 0.140 |
Why?
|
| Tissue Banks | 1 | 2018 | 2 | 0.140 |
Why?
|
| Cattle | 1 | 2018 | 24 | 0.140 |
Why?
|
| Debridement | 1 | 2018 | 12 | 0.140 |
Why?
|
| Weight-Bearing | 1 | 2018 | 43 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 74 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2018 | 154 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 222 | 0.120 |
Why?
|
| Wound Healing | 1 | 2014 | 30 | 0.110 |
Why?
|
| Joint Diseases | 1 | 2014 | 20 | 0.100 |
Why?
|
| Athletic Injuries | 2 | 2013 | 40 | 0.100 |
Why?
|
| Pectoralis Muscles | 1 | 2013 | 5 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2013 | 16 | 0.100 |
Why?
|
| Baseball | 1 | 2013 | 16 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 10 | 0.090 |
Why?
|
| Tendon Transfer | 1 | 2012 | 3 | 0.090 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 1 | 2012 | 5 | 0.090 |
Why?
|
| Femur Head | 1 | 2012 | 13 | 0.090 |
Why?
|
| Acetabulum | 1 | 2012 | 53 | 0.090 |
Why?
|
| Aged | 4 | 2021 | 1860 | 0.080 |
Why?
|
| Reoperation | 2 | 2021 | 146 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2009 | 4 | 0.070 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 59 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 35 | 0.070 |
Why?
|
| Lidocaine | 1 | 2009 | 13 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 10 | 0.070 |
Why?
|
| Tendinopathy | 1 | 2008 | 3 | 0.070 |
Why?
|
| Shoulder Pain | 1 | 2008 | 6 | 0.070 |
Why?
|
| Bupivacaine | 1 | 2008 | 18 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 21 | 0.070 |
Why?
|
| Chondrocytes | 1 | 2008 | 32 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 31 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 44 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 25 | 0.070 |
Why?
|
| Pain | 2 | 2022 | 82 | 0.060 |
Why?
|
| Time Factors | 2 | 2018 | 374 | 0.060 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 17 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2022 | 11 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 19 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 1034 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 66 | 0.040 |
Why?
|
| Range of Motion, Articular | 2 | 2013 | 136 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 4 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 34 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 60 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 165 | 0.030 |
Why?
|
| Graft Survival | 1 | 2017 | 21 | 0.030 |
Why?
|
| United States | 1 | 2018 | 502 | 0.030 |
Why?
|
| Radiography | 1 | 2017 | 129 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 112 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 1 | 2017 | 39 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 6 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 47 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 64 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 112 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 88 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 28 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 40 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2010 | 23 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 57 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 17 | 0.020 |
Why?
|
| Chondromalacia Patellae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2009 | 9 | 0.020 |
Why?
|
| Anesthetics | 1 | 2009 | 7 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 78 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 10 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 4 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 4 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 5 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 33 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 78 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 71 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2008 | 71 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 167 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2009 | 411 | 0.020 |
Why?
|